MENU
GRFS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Grifols SA (GRFS) Ownership - Who owns Grifols SA?
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
Avinguda de la Generalitat, 152
Phone
+34 935712200
Employees
23744
Web
https://www.grifols.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
5.48B
P/E Ratio
68.68
Total Cash
543.64M
Projected Growth
0.27
Total Debt
11.06B
Revenue
6.54B
Risk (Beta)
0.65
Dividend Yield
0.04
Total Cash/Share
0.80
Total Debt/Equity
172.98
Revenue/Share
10.47 USD as % of share price
Fundamentals
GRFS
Capitalization
5.48B
P/E Ratio
68.68
Risk (Beta)
0.65
Dividend Yield
0.04
Total Cash
544M
Total Cash/Share
0.80
Total Debt
11.1B
Total Debt/Equity
172.98
Projected Growth (PEG Ratio)
0.27
Revenue/Share (as % of the share price)
10.47%
Revenue
6.54B
ROE
N/A
Book Value
6.13B
P/B Ratio
0.72
Cash Flow
N/A
Earnings
0.04
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
120M
Current Ratio
2.48
Current Revenue Per Employee
60708.44
Dividends Per Share - Security
0.00
EBITDA
640M
Float
N/A
Float - Current
N/A
Gross Income Margin
39.55
Revenue To Assets
0.11
Shares Held By Institutions
5.56B
Shares Outstanding - Current
679M
Total Liabilities
13.5B
Total Volume MTD
N/A
Value
1
Gain YTD
-4.839
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of plasma-derived biological medicines
Industry PharmaceuticalsMajor
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Avinguda de la Generalitat, 152
Phone
+34 935712200
Employees
23744
Web
https://www.grifols.com